Crescent Biopharma, Inc.
NASDAQ:CBIOBiotechnology
Healthcare
$12.40 -2.69%
-$0.49 today
- Market cap
- $482.30M
- Beta
- 1.15
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$5.33
52W Low $8.72High $27.41
Volume 0.33M
Average 0.28M
Price history
Crescent Biopharma, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-4.62%
Period high
$26.98
Period low
$8.94
Latest
$12.40
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| SC 13G | Oct 27, 2026 | Oct 27, 2026 | |
| 8-K | Oct 15, 2026 | Oct 15, 2026 | |
| 4 | Sep 18, 2026 | Sep 18, 2026 | |
| 4 | Sep 18, 2026 | Sep 18, 2026 | |
| 4 | Sep 18, 2026 | Sep 18, 2026 | |
| 4 | Sep 18, 2026 | Sep 18, 2026 | |
| 4 | Sep 18, 2026 | Sep 18, 2026 | |
| 4 | Sep 18, 2026 | Sep 18, 2026 | |
| 4 | Sep 18, 2026 | Sep 18, 2026 | |
| S-8 | Sep 18, 2026 | Sep 18, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| EFFECT | Jul 31, 2026 | Aug 3, 2026 | |
| 8-K | Jul 30, 2026 | Jul 30, 2026 |
Competitors
Who does Crescent Biopharma, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about CBIO's filings, answered from its disclosures.
What is the latest CBIO filing?
The latest filing shown is 8-K dated Nov 12, 2026.
How many recent filings does CBIO have?
Intrinsic Alpha currently shows 20 recent filings for CBIO.
Continue the stock analysis
Jump to another research area for this company.